Radiofrequency Applications and Alcoholic Neurolysis of Genicular Nerve for the Treatment of Knee Osteoarthritic Pain
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 100 people enrolled
- Started
- 25 Jul 2024
- Ended
- 5 Jan 2025
- Type of study
- Interventional, 4 groups
- Treatments tested
- Radiofrequency
- Alcohol 30%
- Alcohol 50%
- Alcohol 70%
- Record updated
- 28 January 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age > 18 years old
- Both sexes
- Patients with knee osteoarthritis
- Previous conservative treatments longer than 3 months
- visual analog scale (VAS)≥ 4
- Radiological osteoarthritis grades 3 and 4 according to the Kellgren-Lawrence grading system (0 = none, 1 = doubtful, 2 = minimal, 3 = moderate, and 4 = severe)
Who cannot take part
- Anticoagulant therapy
- Injection with steroids or hyaluronic acids during the previous 3 months
- History of knee surgery
- Serious neurologic or psychiatric disorders
- Patient refusal
- Radiculopathy
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to investigate the efficacy of radiofrequency ablation and alcoholic neurolysis of genicular nerve on alleviating pain and improving the function of advanced knee osteoarthritis patients.
The 4 groups in the trial
- Radiofrequency groupTreatment being tested
Patients will receive radiofrequency.
Treatment: Radiofrequency
- 30% alcohol groupTreatment being tested
Patients will receive ultrasound-guided injection of each of the three genicular nerves with 0.5-0.75 ml of a solution containing 30% alcohol in 0.25% bupivacaine.
Treatment: Alcohol 30%
- 50% alcohol groupTreatment being tested
Patients will receive ultrasound-guided injection of each of the three genicular nerves with 0.5-0.75 ml of a solution containing 50% alcohol in 0.25% bupivacaine.
Treatment: Alcohol 50%
- 70% alcohol groupTreatment being tested
Patients will receive ultrasound-guided injection of each of the three genicular nerves with 0.5-0.75 ml of a solution containing 70% alcohol in 0.25% bupivacaine.
Treatment: Alcohol 70%
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Radiofrequency Applications and Alcoholic Neurolysis of Genicular Nerve for the Treatment of Knee Osteoarthritic Pain: A Randomized Trial
- Record updated
- 28 January 2025